Gordon Johnson predicts Tesla's stock could fall to $25 a share, citing its sky-high valuation, slowing sales, and changes in ...

Barclays estimates suggest trading volumes could fall roughly 30% quarter-on-quarter, with global volumes down around 34%, ...

Francesco Catanzariti shared what it's been like to start his hedge fund career as traders ride the 2025 market volatility ...

Costco Wholesale Corporation (NASDAQ:COST) could offer insight at the health of consumer spending when the retailer reports fourth-quarter financial results Thursday after market close. Here are the ...

Analysts expect Nvidia to report fourth-quarter revenue of $65.64 billion, up from $39.33 in last year's fourth quarter, according to data from Benzinga Pro. The company has beaten analyst estimates ...

PANAMA CITY, March 20, 2026 (GLOBE NEWSWIRE) -- BingX, a leading cryptocurrency exchange and Web3-AI company, today announced the launch of BingX AI Claw, a world-first AI trading analyst designed to ...

The crypto market has gone through a wild month as nearly all the cryptocurrencies have lost 20%-30% of their value during the period. XRP, the third-largest cryptocurrency by market cap, has also ...

In the last three months, 4 analysts have published ratings on Genco Shipping & Trading (NYSE:GNK), offering a diverse range of perspectives from bullish to bearish. The table below provides a ...

Palantir Technologies (PLTR) and Rivian Automotive (RIVN) have both received upgrades, with Seeking Alpha analysts pointing ...

Recent upbeat earnings revisions and a strong consensus ranking have put PagSeguro Digital (PAGS) in focus as investors watch how the upcoming results might validate current optimism around the stock.

Today, we are going to highlight three promising clinical-stage biotech stocks. One thing they have in common is each equity is trading for way below the median analyst firm price target on the shares ...